Nifty

:

24008.00

Sensex

:

79454.47

-265.80 (-1.09%)
-880.34 (-1.10%)

Login

Nifty
Sensex

:
:

24008.00
79454.47

-265.80 (-1.09%)
-880.34 (-1.10%)

Kovai Medical Center & Hospital Ltd.

Hospital & Healthcare Services

Rating :

N/A

BSE: 523323 | NSE: KOVAI

Watchlist

NSE BSE

5983.55

06-Feb-2025

Open
High
Low
Previous Close

5800.00
6042.95
5774.00
5750.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

7592
452.50
6400.00
3833.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,126.63
29.68
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,257.79
0.18%
5.94

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.75
11.37
10.44

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.87
15.09
5.86

PAT CAGR (%)

10 Years
5 Years
3 Years

16.60
13.70
19.90

P:E (Median)

8 Years
5 Years
3 Years

18.18
19.20
25.05

P:BV (Average)

8 Years
5 Years
3 Years

3.61
3.69
4.35

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.54
10.23
11.60

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 164.25
P/E Ratio 31.65
Revenue 1209
EBITDA 342
Net Income 180
ROA 12.5
P/B Ratio 6.4
ROE 22.36
FCFF 177.12
FCFF Yield 3.07

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 355.04 321.11 10.57% 344.00 302.73 13.63% 315.11 274.61 14.75% 321.11 266.99 20.27%
Expenses 252.14 224.77 12.18% 248.49 217.46 14.27% 228.85 206.19 10.99% 229.45 199.90 14.78%
EBITDA 102.89 96.34 6.80% 95.50 85.26 12.01% 86.26 68.42 26.07% 91.67 67.08 36.66%
EBIDTM 28.98% 30.00% 27.76% 28.17% 27.37% 24.92% 28.55% 25.13%
Other Income 6.01 4.87 23.41% 4.53 4.35 4.14% 5.14 6.09 -15.60% 5.65 5.23 8.03%
Interest 9.16 7.34 24.80% 8.24 8.26 -0.24% 6.63 10.45 -36.56% 6.89 9.96 -30.82%
Depreciation 24.62 23.34 5.48% 24.39 22.96 6.23% 24.06 22.31 7.84% 23.52 21.68 8.49%
PBT 75.13 70.52 6.54% 67.40 58.39 15.43% 60.71 41.75 45.41% 66.91 40.67 64.52%
Tax 17.33 17.42 -0.52% 16.71 14.98 11.55% 14.96 10.70 39.81% 14.73 10.12 45.55%
PAT 57.80 53.10 8.85% 50.69 43.41 16.77% 45.75 31.05 47.34% 52.18 30.56 70.75%
PATM 16.28% 16.54% 14.74% 14.34% 14.52% 11.31% 16.25% 11.45%
EPS 53.03 48.71 8.87% 46.50 39.82 16.78% 41.98 28.49 47.35% 47.87 28.03 70.78%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,335.26 1,219.55 1,019.75 905.33 690.36 711.73 628.39 592.37 531.07 465.30 401.62 Net Sales Growth 14.57% 19.59% 12.64% 31.14% -3.00% 13.26% 6.08% 11.54% 14.13% 15.86% Cost Of Goods Sold 358.75 323.90 282.84 256.27 193.55 204.80 187.37 172.08 159.74 143.92 122.42 Gross Profit 976.51 895.65 736.90 649.05 496.81 506.93 441.02 420.29 371.33 321.38 279.20 GP Margin 73.13% 73.44% 72.26% 71.69% 71.96% 71.23% 70.18% 70.95% 69.92% 69.07% 69.52% Total Expenditure 958.93 874.14 748.13 645.54 495.00 540.66 493.52 463.56 406.38 373.59 307.34 Power & Fuel Cost - 20.07 16.31 16.94 8.36 8.66 8.64 11.37 10.42 10.20 9.74 % Of Sales - 1.65% 1.60% 1.87% 1.21% 1.22% 1.37% 1.92% 1.96% 2.19% 2.43% Employee Cost - 219.47 179.70 150.76 118.67 124.87 111.58 98.22 87.73 79.36 64.60 % Of Sales - 18.00% 17.62% 16.65% 17.19% 17.54% 17.76% 16.58% 16.52% 17.06% 16.08% Manufacturing Exp. - 82.55 67.02 53.61 37.44 43.49 151.81 146.69 128.17 121.88 98.13 % Of Sales - 6.77% 6.57% 5.92% 5.42% 6.11% 24.16% 24.76% 24.13% 26.19% 24.43% General & Admin Exp. - 218.93 191.29 156.59 126.88 149.60 26.31 23.45 12.88 17.44 12.19 % Of Sales - 17.95% 18.76% 17.30% 18.38% 21.02% 4.19% 3.96% 2.43% 3.75% 3.04% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 9.23 10.96 11.38 10.09 9.26 7.82 11.76 7.44 0.78 0.00 % Of Sales - 0.76% 1.07% 1.26% 1.46% 1.30% 1.24% 1.99% 1.40% 0.17% 0.07% EBITDA 376.32 345.41 271.62 259.79 195.36 171.07 134.87 128.81 124.69 91.71 94.28 EBITDA Margin 28.18% 28.32% 26.64% 28.70% 28.30% 24.04% 21.46% 21.74% 23.48% 19.71% 23.47% Other Income 21.33 20.95 15.99 12.50 11.85 10.59 8.24 7.63 6.18 7.75 6.73 Interest 30.92 36.67 43.26 46.17 33.46 17.63 14.73 12.86 14.72 16.66 20.38 Depreciation 96.59 92.14 89.13 85.43 68.03 52.12 35.53 34.16 23.81 20.64 21.20 PBT 270.15 237.56 155.22 140.68 105.74 111.91 92.84 89.42 92.34 62.16 59.43 Tax 63.73 57.83 39.45 36.42 28.05 17.33 32.70 31.44 32.36 21.73 20.73 Tax Rate 23.59% 24.34% 25.42% 25.89% 26.53% 15.49% 35.22% 35.16% 35.04% 34.96% 34.88% PAT 206.42 179.73 115.77 104.26 77.69 94.59 60.14 57.98 59.97 40.43 38.70 PAT before Minority Interest 206.42 179.73 115.77 104.26 77.69 94.59 60.14 57.98 59.97 40.43 38.70 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.46% 14.74% 11.35% 11.52% 11.25% 13.29% 9.57% 9.79% 11.29% 8.69% 9.64% PAT Growth 30.55% 55.25% 11.04% 34.20% -17.87% 57.28% 3.73% -3.32% 48.33% 4.47% EPS 189.38 164.89 106.21 95.65 71.28 86.78 55.17 53.19 55.02 37.09 35.50

Description TTM Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Net Sales - 592.37 531.07 465.30 401.62 334.06 297.13 222.37 174.72 130.07 110.36 Net Sales Growth - 11.54% 14.13% 15.86% 20.22% 12.43% 33.62% 27.27% 34.33% 17.86% Cost Of Goods Sold - 172.08 159.74 143.92 122.42 105.83 91.74 72.37 56.59 42.04 37.43 Gross Profit - 420.29 371.33 321.38 279.20 228.23 205.39 150.00 118.13 88.03 72.93 GP Margin - 70.95% 69.92% 69.07% 69.52% 68.32% 69.12% 67.46% 67.61% 67.68% 66.08% Total Expenditure - 463.26 406.10 373.17 306.97 260.77 226.17 178.20 137.89 104.36 91.34 Power & Fuel Cost - 11.37 10.42 10.20 9.74 9.49 10.26 8.36 6.76 4.79 4.49 % Of Sales - 1.92% 1.96% 2.19% 2.43% 2.84% 3.45% 3.76% 3.87% 3.68% 4.07% Employee Cost - 98.22 87.73 79.36 64.60 52.69 48.69 32.51 22.72 16.50 12.95 % Of Sales - 16.58% 16.52% 17.06% 16.08% 15.77% 16.39% 14.62% 13.00% 12.69% 11.73% Manufacturing Exp. - 146.69 128.17 121.88 98.13 81.85 67.14 56.53 46.16 36.03 31.48 % Of Sales - 24.76% 24.13% 26.19% 24.43% 24.50% 22.60% 25.42% 26.42% 27.70% 28.52% General & Admin Exp. - 23.16 12.60 17.02 11.81 10.91 8.33 8.43 5.66 4.86 4.83 % Of Sales - 3.91% 2.37% 3.66% 2.94% 3.27% 2.80% 3.79% 3.24% 3.74% 4.38% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 11.75 7.43 0.78 0.27 0.00 0.00 0.00 0.00 0.13 0.00 % Of Sales - 1.98% 1.40% 0.17% 0.07% 0% 0% 0% 0% 0.10% 0.14% EBITDA - 129.11 124.97 92.13 94.65 73.29 70.96 44.17 36.83 25.71 19.02 EBITDA Margin - 21.80% 23.53% 19.80% 23.57% 21.94% 23.88% 19.86% 21.08% 19.77% 17.23% Other Income - 7.52 6.04 7.61 6.60 4.51 2.84 1.26 0.93 1.56 0.87 Interest - 12.86 14.72 16.66 20.38 23.94 27.46 16.58 11.11 4.84 4.44 Depreciation - 34.33 23.87 20.74 21.61 16.47 15.83 12.61 7.11 5.19 4.42 PBT - 89.44 92.43 62.34 59.26 37.39 30.51 16.24 19.53 17.25 11.03 Tax - 31.46 32.36 21.73 20.73 13.61 10.09 4.30 7.43 5.65 3.89 Tax Rate - 35.17% 35.01% 34.86% 34.98% 36.40% 33.07% 26.48% 38.04% 32.75% 35.27% PAT - 57.98 60.06 40.62 38.53 23.77 20.43 11.94 12.10 11.60 7.14 PAT before Minority Interest - 57.98 60.06 40.62 38.53 23.77 20.43 11.94 12.10 11.60 7.14 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 9.79% 11.31% 8.73% 9.59% 7.12% 6.88% 5.37% 6.93% 8.92% 6.47% PAT Growth - -3.46% 47.86% 5.42% 62.10% 16.35% 71.11% -1.32% 4.31% 62.46% EPS - 53.19 55.10 37.27 35.35 21.81 18.74 10.95 11.10 10.64 6.55

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 888.54 719.04 609.31 510.00 431.04 343.24 289.99 235.34 175.55 138.41 Share Capital 10.94 10.94 10.94 10.94 10.94 10.94 10.94 10.94 10.94 10.94 Total Reserves 877.60 708.10 598.37 499.06 420.09 332.30 279.05 224.40 164.61 127.46 Non-Current Liabilities 345.15 537.92 570.33 632.58 571.51 385.18 211.95 132.13 162.48 160.17 Secured Loans 253.18 447.37 483.37 550.72 504.64 335.96 164.56 85.72 120.79 127.59 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 20.21 18.81 14.95 9.38 8.51 8.00 7.01 5.80 5.66 3.47 Current Liabilities 204.54 181.16 163.02 138.58 104.66 121.19 105.59 96.44 91.52 87.58 Trade Payables 26.39 27.33 14.22 15.46 25.93 23.91 20.22 16.25 18.72 17.67 Other Current Liabilities 172.04 147.88 131.54 108.46 70.70 84.04 81.16 72.51 63.08 60.40 Short Term Borrowings 0.00 0.09 10.07 8.77 3.76 9.44 0.09 4.33 5.52 4.83 Short Term Provisions 6.11 5.85 7.19 5.88 4.27 3.80 4.12 3.35 4.20 4.68 Total Liabilities 1,438.23 1,438.12 1,342.66 1,281.16 1,107.21 849.61 607.53 463.91 429.55 386.16 Net Block 1,117.68 1,087.55 1,084.54 1,033.01 642.77 469.30 440.04 354.04 337.49 280.93 Gross Block 1,578.89 1,459.67 1,373.66 1,243.67 786.73 561.39 482.91 377.29 452.84 378.14 Accumulated Depreciation 461.21 372.13 289.12 210.66 143.96 92.09 42.86 23.25 115.35 97.22 Non Current Assets 1,187.82 1,143.07 1,104.52 1,093.13 966.90 720.37 486.74 372.25 358.80 309.51 Capital Work in Progress 38.63 23.32 5.46 45.27 299.60 227.30 12.88 5.65 10.10 16.67 Non Current Investment 0.45 0.26 0.20 0.16 0.12 0.24 3.80 3.89 3.72 3.72 Long Term Loans & Adv. 30.19 18.85 12.37 10.42 21.19 21.81 30.02 8.67 7.49 8.19 Other Non Current Assets 0.86 13.08 1.96 4.27 3.23 1.72 0.00 0.00 0.00 0.00 Current Assets 250.41 295.05 238.13 188.02 140.31 129.24 120.80 91.66 70.75 76.65 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 14.70 13.72 12.58 10.23 12.66 10.13 10.83 8.78 8.55 8.32 Sundry Debtors 16.81 21.35 19.32 14.00 8.42 10.01 13.82 11.75 8.97 10.10 Cash & Bank 211.06 248.59 198.24 154.58 110.94 101.89 92.22 68.13 50.94 55.51 Other Current Assets 7.85 7.95 5.74 8.09 8.29 7.21 3.93 3.00 2.29 2.72 Short Term Loans & Adv. 0.81 3.44 2.25 1.12 0.26 0.38 0.12 0.20 0.60 0.40 Net Current Assets 45.87 113.89 75.11 49.45 35.65 8.05 15.20 -4.79 -20.77 -10.93 Total Assets 1,438.23 1,438.12 1,342.65 1,281.15 1,107.21 849.61 607.54 463.91 429.55 386.16

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Shareholder's Funds 288.56 233.90 174.02 136.70 101.20 79.34 60.83 50.48 39.97 29.96 Share Capital 10.94 10.94 10.94 10.94 10.94 10.94 10.94 10.94 10.94 10.94 Total Reserves 277.61 222.96 163.08 125.76 90.25 68.40 49.89 39.54 29.03 19.02 Non-Current Liabilities 211.95 132.13 162.48 160.17 185.68 205.39 224.61 190.57 116.04 77.34 Secured Loans 164.56 85.72 120.79 127.59 154.14 179.43 203.45 174.88 108.06 70.04 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.34 Long Term Provisions 7.01 5.80 5.66 3.47 3.71 3.26 2.49 2.01 0.00 0.00 Current Liabilities 105.61 96.46 91.54 87.60 62.73 58.90 52.95 42.36 17.25 18.17 Trade Payables 20.22 16.25 18.72 17.67 10.25 7.39 6.45 3.93 7.17 3.86 Other Current Liabilities 81.18 72.52 63.09 60.42 44.84 43.61 38.78 30.50 6.26 11.00 Short Term Borrowings 0.09 4.33 5.52 4.83 4.19 4.54 4.97 5.06 0.00 0.00 Short Term Provisions 4.12 3.35 4.20 4.68 3.45 3.35 2.75 2.88 3.82 3.31 Total Liabilities 606.12 462.49 428.04 384.47 349.61 343.63 338.39 283.41 173.26 125.47 Net Block 443.84 358.01 341.52 285.07 282.36 284.82 295.16 192.51 106.20 68.93 Gross Block 486.93 381.32 460.48 386.32 371.64 360.01 359.05 243.79 150.74 108.30 Accumulated Depreciation 43.09 23.30 118.96 101.25 89.28 74.18 63.89 51.28 44.54 39.37 Non Current Assets 485.13 370.52 357.16 307.56 295.51 298.27 301.23 241.63 148.44 89.05 Capital Work in Progress 12.88 5.65 10.10 16.67 4.94 4.72 0.15 38.10 42.21 20.09 Non Current Investment 0.23 0.31 0.15 0.15 0.03 0.03 0.03 0.03 0.03 0.03 Long Term Loans & Adv. 28.19 6.55 5.40 5.67 8.19 8.71 5.89 10.99 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 120.99 91.96 70.88 76.92 54.10 45.36 37.16 41.77 24.82 36.42 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 10.83 8.78 8.55 8.32 9.68 8.92 7.26 5.76 5.00 3.95 Sundry Debtors 13.82 11.75 8.97 10.10 7.25 4.15 3.20 6.63 4.32 3.28 Cash & Bank 92.41 68.43 51.06 55.76 35.32 31.15 25.86 28.97 13.03 21.57 Other Current Assets 3.93 2.81 1.70 2.32 1.85 1.14 0.84 0.42 2.47 7.63 Short Term Loans & Adv. 0.12 0.20 0.60 0.40 0.29 0.12 0.09 0.12 1.75 6.83 Net Current Assets 15.38 -4.49 -20.66 -10.68 -8.64 -13.54 -15.79 -0.59 7.57 18.25 Total Assets 606.12 462.48 428.04 384.48 349.61 343.63 338.39 283.40 173.26 125.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 344.13 262.91 261.79 185.75 151.96 126.05 86.89 98.79 84.61 97.20 PBT 237.56 155.22 140.68 105.74 111.91 92.84 89.42 92.34 62.16 59.43 Adjustment 122.99 129.33 129.45 98.08 67.71 47.66 41.18 33.77 32.27 37.30 Changes in Working Capital 40.70 15.65 30.27 3.85 2.72 16.76 -11.33 -2.05 5.88 15.76 Cash after chg. in Working capital 401.25 300.21 300.40 207.67 182.34 157.26 119.27 124.06 100.31 112.49 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -57.11 -37.30 -38.61 -21.92 -30.39 -31.21 -32.38 -25.27 -15.70 -15.29 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -138.17 -126.86 -99.10 -180.48 -255.70 -276.63 -122.77 -32.02 -64.96 -33.36 Net Fixed Assets -134.53 -103.87 -90.18 -202.61 -297.64 -292.90 -112.85 80.00 -68.13 -29.01 Net Investments -0.19 -0.06 -0.04 -0.04 0.12 3.56 0.09 -0.17 0.00 -0.12 Others -3.45 -22.93 -8.88 22.17 41.82 12.71 -10.01 -111.85 3.17 -4.23 Cash from Financing Activity -243.49 -85.70 -119.04 38.38 112.78 160.07 59.97 -49.58 -24.23 -43.25 Net Cash Inflow / Outflow -37.53 50.35 43.66 43.64 9.04 9.49 24.09 17.19 -4.57 20.58 Opening Cash & Equivalents 248.59 198.24 154.58 110.94 101.89 92.41 68.13 50.94 55.51 34.93 Closing Cash & Equivalent 211.06 248.59 5.45 6.93 32.09 26.73 23.65 17.50 2.40 9.36

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Cash From Operating Activity 86.89 99.11 85.91 97.14 67.99 61.12 56.32 41.99 23.90 15.28 PBT 89.44 92.43 62.34 59.26 37.39 30.51 16.24 19.53 17.25 11.03 Adjustment 41.47 33.97 32.53 37.91 38.45 41.57 28.73 18.02 9.28 8.67 Changes in Working Capital -11.83 -1.98 6.64 15.22 -0.19 -4.22 15.10 7.86 2.54 -1.22 Cash after chg. in Working capital 119.07 124.42 101.51 112.39 75.64 67.87 60.08 45.41 29.06 18.49 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -32.18 -25.31 -15.60 -15.25 -7.65 -6.76 -3.75 -3.43 -5.16 -3.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -122.73 -32.01 -66.39 -33.44 -12.27 -8.33 -76.85 -97.47 -63.83 -23.49 Net Fixed Assets -112.85 80.00 -68.13 -29.01 -11.85 -6.02 -77.31 -88.94 -64.56 Net Investments 0.09 -0.17 0.00 -0.12 0.00 0.00 0.00 0.00 0.00 Others -9.97 -111.84 1.74 -4.31 -0.42 -2.31 0.46 -8.53 0.73 Cash from Financing Activity 59.83 -49.73 -24.23 -43.25 -51.56 -47.50 17.42 71.42 31.38 26.64 Net Cash Inflow / Outflow 23.98 17.37 -4.71 20.45 4.17 5.29 -3.10 15.94 -8.54 18.42 Opening Cash & Equivalents 68.43 51.06 55.76 35.32 31.15 25.86 28.97 13.03 21.57 3.15 Closing Cash & Equivalent 23.68 17.52 2.43 9.43 10.58 31.15 25.86 28.97 13.03 21.57

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 812.02 657.12 556.84 466.08 393.92 313.69 265.02 215.07 160.43 126.49 ROA 12.50% 8.33% 7.95% 6.51% 9.67% 8.25% 10.82% 13.43% 9.91% 10.50% ROE 22.36% 17.43% 18.63% 16.51% 24.43% 19.00% 22.07% 29.19% 25.76% 32.16% ROCE 23.29% 17.15% 16.86% 13.66% 15.56% 17.74% 24.00% 30.82% 24.83% 27.19% Fixed Asset Turnover 0.80 0.72 0.69 0.68 1.06 1.20 1.38 1.28 1.12 1.09 Receivable days 5.71 7.28 6.72 5.93 4.73 6.92 7.88 7.12 7.48 7.89 Inventory Days 4.25 4.71 4.60 6.05 5.84 6.09 6.04 5.95 6.62 8.18 Payable days 30.27 26.81 21.13 39.03 20.96 16.27 14.39 15.57 17.64 16.11 Cash Conversion Cycle -20.31 -14.82 -9.82 -27.05 -10.39 -3.26 -0.47 -2.49 -3.54 -0.04 Total Debt/Equity 0.31 0.66 0.84 1.15 1.19 1.10 0.70 0.53 0.90 1.18 Interest Cover 7.48 4.59 4.05 4.16 7.35 7.30 7.95 7.27 4.73 3.92

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09
Book Value (Rs.) 263.71 213.76 159.04 124.93 92.48 72.51 55.59 46.13 36.53 27.38 ROA 10.85% 13.49% 10.00% 10.50% 6.86% 5.99% 3.84% 5.30% 7.77% 6.54% ROE 22.19% 29.45% 26.14% 32.40% 26.34% 29.15% 21.46% 26.76% 33.18% 25.51% ROCE 24.08% 30.98% 25.01% 27.26% 21.39% 20.08% 12.35% 15.68% 17.78% 18.85% Fixed Asset Turnover 1.36 1.26 1.10 1.06 0.91 0.83 0.74 0.89 1.00 1.08 Receivable days 7.88 7.12 7.48 7.89 6.23 4.52 8.06 11.43 10.65 10.79 Inventory Days 6.04 5.95 6.62 8.18 10.16 9.94 10.68 11.24 12.56 13.14 Payable days 14.38 15.57 17.64 16.09 12.09 10.81 10.38 14.53 19.11 20.62 Cash Conversion Cycle -0.46 -2.49 -3.54 -0.02 4.30 3.64 8.36 8.14 4.10 3.30 Total Debt/Equity 0.70 0.54 0.91 1.19 1.81 2.64 3.74 3.81 2.71 2.35 Interest Cover 7.95 7.28 4.74 3.91 2.56 2.11 1.98 2.76 4.57 3.49

Top Investors:

dsp business cycle fund

investor education and protection fund (iepf)

quant mutual fund - quant business cycle fund

Annual Reports:

News Update:

Kovai Medical Center & Hospital gets nod to purchase land, building in Tamil Nadu
19th Mar 2025, 16:30 PM

The Board of directors of the company at their meeting held on March 18, 2025, has approved the same
Read More
Kovai Medical Center - Quarterly Results
7th Feb 2025, 19:03 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback